{
    "xml": "<topic id=\"PHP2978\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/sodium-valproate\" basename=\"sodium-valproate\" title=\"SODIUM VALPROATE\">\n<title>SODIUM VALPROATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_286\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/sodium-valproate\">Sodium Valproate</xref>\n</p>\n<data name=\"vtmid\">10049011000001109</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_926692410\" title=\"Antiepileptics\">Antiepileptics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP64889\" outputclass=\"indicationsAndDose\" rev=\"1.77\" parent=\"/drugs/sodium-valproate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>Initially 10&#8211;15&#8239;mg/kg daily in 1&#8211;2 divided doses (max. per dose 600&#8239;mg); maintenance 25&#8211;30&#8239;mg/kg daily in 2 divided doses, doses up to 60&#8239;mg/kg daily in 2 divided doses may be used in infantile spasms; monitor clinical chemistry and haematological parameters if dose exceeds 40&#8239;mg/kg daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 600&#8239;mg daily in 1&#8211;2 divided doses, increased in steps of 150&#8211;300&#8239;mg every 3&#8239;days; maintenance 1&#8211;2&#8239;g daily in 2 divided doses; maximum 2.5&#8239;g per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 600&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 150&#8211;300&#8239;mg every 3&#8239;days; maintenance 1&#8211;2&#8239;g daily, alternatively maintenance 20&#8211;30&#8239;mg/kg daily; maximum 2.5&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Initiation of valproate treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;mg/kg, (Usually 400&#8211;800&#8239;mg), followed by (by intravenous infusion or by intravenous injection) up to 2.5&#8239;g daily in 2&#8211;4 divided doses, alternatively (by continuous intravenous infusion) up to 2.5&#8239;g daily; (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 1&#8211;2&#8239;g daily, alternatively (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 20&#8211;30&#8239;mg/kg daily, intravenous injection to be administered over 3&#8211;5 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Continuation of valproate treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion or by continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>If switching from oral therapy to intravenous therapy give current oral daily dose, give over 3&#8211;5 minutes by intravenous injection <i>or</i> in 2&#8211;4 divided doses by intravenous infusion.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Migraine prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 200&#8239;mg twice daily, then increased if necessary to 1.2&#8211;1.5&#8239;g daily in divided doses.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48956\" outputclass=\"unlicensedUse\" rev=\"1.16\" parent=\"/drugs/sodium-valproate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Not licensed for migraine prophylaxis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65379\" outputclass=\"contraindications\" rev=\"1.28\" parent=\"/drugs/sodium-valproate\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Family history of severe hepatic dysfunction</ph>; <ph outputclass=\"contraindication\">known mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)</ph>; <ph outputclass=\"contraindication\">personal or family history of severe hepatic dysfunction</ph>; <ph outputclass=\"contraindication\">porphyria</ph>; <ph outputclass=\"contraindication\">suspected mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65474\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/sodium-valproate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Systemic lupus erythematosus</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Liver toxicity</p>\n<p>Liver dysfunction (including fatal hepatic failure) has occurred in association with valproate (especially in children under 3 years and in those with metabolic or degenerative disorders, organic brain disease or severe seizure disorders associated with mental retardation) usually in first 6 months and usually involving multiple antiepileptic therapy. Raised liver enzymes during valproate treatment are usually transient but patients should be reassessed clinically and liver function (including prothrombin time) monitored until return to normal&#8212;discontinue if abnormally prolonged prothrombin time (particularly in association with other relevant abnormalities).</p>\n</sectiondiv>\n<sectiondiv>\n<p>Consider vitamin D supplementation in patients that are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64846\" outputclass=\"interactions\" rev=\"1.21\" parent=\"/drugs/sodium-valproate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (sodium valproate).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49177\" outputclass=\"sideEffects\" rev=\"1.35\" parent=\"/drugs/sodium-valproate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Aggression</ph>; <ph outputclass=\"sideEffect\">anaemia</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsion</ph>; <ph outputclass=\"sideEffect\">deafness</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">extrapyramidal disorders</ph>; <ph outputclass=\"sideEffect\">gastric irritation</ph>; <ph outputclass=\"sideEffect\">haemorrhage</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyponatraemia</ph>; <ph outputclass=\"sideEffect\">memory impairment</ph>; <ph outputclass=\"sideEffect\">menstrual disturbance</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nystagmus</ph>; <ph outputclass=\"sideEffect\">somnolence</ph>; <ph outputclass=\"sideEffect\">stupor</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">transient hair loss (regrowth may be curly)</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">weight gain</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Angioedema</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">coma</ph>; <ph outputclass=\"sideEffect\">encephalopathy</ph>; <ph outputclass=\"sideEffect\">increased alertness</ph>; <ph outputclass=\"sideEffect\">lethargy</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">pancytopenia</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">reduced bone mineral density</ph>; <ph outputclass=\"sideEffect\">syndrome of inappropriate secretion of antidiuretic hormone</ph>; <ph outputclass=\"sideEffect\">vasculitis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Behavioural disturbance</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">bone marrow failure</ph>; <ph outputclass=\"sideEffect\">dementia</ph> (in adults); <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">drug rash with eosinophilia and systemic symptoms (DRESS) syndrome</ph>; <ph outputclass=\"sideEffect\">enuresis</ph>; <ph outputclass=\"sideEffect\">Fanconi&#8217;s syndrome</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">hearing loss</ph>; <ph outputclass=\"sideEffect\">hyperactivity</ph>; <ph outputclass=\"sideEffect\">hyperammonaemia</ph>; <ph outputclass=\"sideEffect\">hypothyroidism</ph>; <ph outputclass=\"sideEffect\">learning disorders</ph>; <ph outputclass=\"sideEffect\">male infertility</ph>; <ph outputclass=\"sideEffect\">myelodysplastic syndrome</ph>; <ph outputclass=\"sideEffect\">polycystic ovaries</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">systemic lupus erythematosus</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acne</ph>; <ph outputclass=\"sideEffect\">gynaecomastia</ph>; <ph outputclass=\"sideEffect\">hepatic dysfunction</ph>; <ph outputclass=\"sideEffect\">hirsutism</ph>; <ph outputclass=\"sideEffect\">increase in bleeding time</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">suicidal ideation</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Hepatic dysfunction</p>\n<p>Withdraw treatment immediately if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness, or loss of seizure control.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65424\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/sodium-valproate\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Valproate is associated with teratogenic risks and should not be used in women of child-bearing potential unless there is no safer alternative&#8212;this should be fully considered and discussed before prescribing for women of child-bearing age.</p>\n<p>Effective contraception advised in women of child-bearing potential.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64779\" outputclass=\"pregnancy\" parent=\"/drugs/sodium-valproate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Valproate is associated with the highest risk of major and minor congenital malformations (in particular neural tube defects), and long-term neurodevelopmental effects. Valproate should not be used during pregnancy or in women of child-bearing potential unless there is no safer alternative and only after a careful discussion of the risks. </p>\n<p>If valproate is to be used during pregnancy, the lowest effective dose should be prescribed in divided doses or as modified-release tablets to avoid peaks in plasma-valproate concentrations; doses greater than 1&#8239;g daily are associated with an increased risk of teratogenicity.</p>\n<p>Avoid use in the treatment of epilepsy and bipolar disorder unless there is no safer alternative and only after a careful discussion of the risks&#8212;effective contraception advised in women of child-bearing potential.</p>\n<p>Avoid use for the prophylaxis of migraine [unlicensed]&#8212;exclude pregnancy before treatment and ensure effective contraception is used during treatment.</p>\n<p>Neonatal bleeding (related to hypofibrinaemia) reported.</p>\n<p>Neonatal hepatotoxicity also reported.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInPregnancy\">\n<sectiondiv>\n<p>Specialist prenatal monitoring should be instigated when valproate has been taken in pregnancy.</p>\n<p>The dose should be monitored carefully during pregnancy and after birth, and adjustments made on a clinical basis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65556\" outputclass=\"breastFeeding\" parent=\"/drugs/sodium-valproate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk&#8212;risk of haematological disorders in breast-fed new borns and infants.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65048\" outputclass=\"hepaticImpairment\" parent=\"/drugs/sodium-valproate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if possible&#8212;hepatotoxicity and hepatic failure may occasionally occur (usually in first 6 months).</p>\n<p>Avoid in active liver disease.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64592\" outputclass=\"renalImpairment\" parent=\"/drugs/sodium-valproate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48926\" outputclass=\"monitoringRequirements\" parent=\"/drugs/sodium-valproate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p>Plasma-valproate concentrations are not a useful index of efficacy, therefore routine monitoring is unhelpful.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor liver function before therapy and during first 6 months especially in patients most at risk.</p>\n<p>Measure full blood count and ensure no undue potential for bleeding before starting and before surgery.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48763\" outputclass=\"effectOnLaboratoryTests\" rev=\"1.7\" parent=\"/drugs/sodium-valproate\">\n<title>Effect on laboratory tests</title>\n<body>\n<section>\n<sectiondiv>\n<p>False-positive urine tests for ketones.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65658\" outputclass=\"directionsForAdministration\" rev=\"1.25\" parent=\"/drugs/sodium-valproate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous injection</i>, may be diluted in Glucose 5% <i>or</i> Sodium Chloride 0.9% and given over 3&#8211;5 minutes.</p>\n<p>For <i>intravenous infusion</i>, dilute injection solution with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">rectal</ph> use in children</p>\n<p>For <i>rectal administration</i>, sodium valproate oral solution may be given rectally and retained for 15 minutes (may require dilution with water to prevent rapid expulsion).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Epilim</i>\n<tm tmtype=\"reg\"/>, <i>Episenta</i>\n<tm tmtype=\"reg\"/>), give continuously <i>or</i> intermittently <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%. Reconstitute <i>Epilim</i>\n<tm tmtype=\"reg\"/> with solvent provided then dilute with infusion fluid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57740\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.11\" parent=\"/drugs/sodium-valproate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Switching between formulations</p>\n<p>Care should be taken when switching between oral formulations in the treatment of epilepsy. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p>\n<p>Patients being treated for epilepsy may need to be maintained on a specific manufacturer&#8217;s branded or generic oral sodium valproate product.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64705\" outputclass=\"patientAndCarerAdvice\" rev=\"1.32\" parent=\"/drugs/sodium-valproate\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Sodium valproate for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures\">www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Blood or hepatic disorders</p>\r\n<p>Patients or their carers should be told how to recognise signs and symptoms of blood or liver disorders and advised to seek immediate medical attention if symptoms develop.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Pancreatitis</p>\r\n<p>Patients or their carers should be told how to recognise signs and symptoms of pancreatitis and advised to seek immediate medical attention if symptoms such as abdominal pain, nausea, or vomiting develop; discontinue if pancreatitis is diagnosed.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n<section outputclass=\"patientAdviceInPregnancy\">\r\n<sectiondiv>\r\n<p>Counselling advised on pregnancy.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP2978-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/sodium-valproate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: suppository, oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77460\" title=\"Tablet\" namespace=\"/drugs/sodium-valproate/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77472\" title=\"Modified-release tablet\" namespace=\"/drugs/sodium-valproate/modified-release-tablet\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77467\" title=\"Gastro-resistant tablet\" namespace=\"/drugs/sodium-valproate/gastro-resistant-tablet\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77482\" title=\"Modified-release capsule\" namespace=\"/drugs/sodium-valproate/modified-release-capsule\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77496\" title=\"Modified-release granules\" namespace=\"/drugs/sodium-valproate/modified-release-granules\">Modified-release granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77491\" title=\"Oral solution\" namespace=\"/drugs/sodium-valproate/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76148\" title=\"Solution for injection\" namespace=\"/drugs/sodium-valproate/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77476\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/sodium-valproate/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78155\" namespace=\"/treatment-summaries/psychoses-and-related-disorders\" title=\"Psychoses and related disorders\" count=\"2\" rel=\"backlink\">Psychoses and related disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"15\" rel=\"backlink\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"1\" rel=\"backlink\">Migraine</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_286\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/sodium-valproate\" title=\"Sodium Valproate\" count=\"1\" rel=\"link\">Sodium Valproate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77460\" namespace=\"/drugs/sodium-valproate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77472\" namespace=\"/drugs/sodium-valproate/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77467\" namespace=\"/drugs/sodium-valproate/gastro-resistant-tablet\" title=\"Gastro-resistant tablet\" count=\"1\" rel=\"link\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77482\" namespace=\"/drugs/sodium-valproate/modified-release-capsule\" title=\"Modified-release capsule\" count=\"1\" rel=\"link\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77496\" namespace=\"/drugs/sodium-valproate/modified-release-granules\" title=\"Modified-release granules\" count=\"1\" rel=\"link\">Modified-release granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77491\" namespace=\"/drugs/sodium-valproate/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76148\" namespace=\"/drugs/sodium-valproate/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77476\" namespace=\"/drugs/sodium-valproate/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP2978",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/sodium-valproate",
    "basename": "sodium-valproate",
    "title": "SODIUM VALPROATE",
    "interactants": [
        {
            "id": "bnf_int_286",
            "label": "Sodium Valproate"
        }
    ],
    "vtmid": "10049011000001109",
    "drugClassification": [
        "Antiepileptics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "All forms of epilepsy",
                        "html": "All forms of epilepsy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using immediate-release medicines"
                    ],
                    "textContent": "By mouth using immediate-release medicines",
                    "html": "By mouth using immediate-release medicines"
                },
                "child": [
                    {
                        "textContent": "Initially 10&#8211;15 mg/kg daily in 1&#8211;2 divided doses (max. per dose 600 mg); maintenance 25&#8211;30 mg/kg daily in 2 divided doses, doses up to 60 mg/kg daily in 2 divided doses may be used in infantile spasms; monitor clinical chemistry and haematological parameters if dose exceeds 40 mg/kg daily.",
                        "html": "<p>Initially 10&#8211;15&#8239;mg/kg daily in 1&#8211;2 divided doses (max. per dose 600&#8239;mg); maintenance 25&#8211;30&#8239;mg/kg daily in 2 divided doses, doses up to 60&#8239;mg/kg daily in 2 divided doses may be used in infantile spasms; monitor clinical chemistry and haematological parameters if dose exceeds 40&#8239;mg/kg daily.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 600 mg daily in 1&#8211;2 divided doses, increased in steps of 150&#8211;300 mg every 3 days; maintenance 1&#8211;2 g daily in 2 divided doses; maximum 2.5 g per day.",
                        "html": "<p>Initially 600&#8239;mg daily in 1&#8211;2 divided doses, increased in steps of 150&#8211;300&#8239;mg every 3&#8239;days; maintenance 1&#8211;2&#8239;g daily in 2 divided doses; maximum 2.5&#8239;g per day.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 600 mg daily in 1&#8211;2 divided doses, then increased in steps of 150&#8211;300 mg every 3 days; maintenance 1&#8211;2 g daily, alternatively maintenance 20&#8211;30 mg/kg daily; maximum 2.5 g per day.",
                        "html": "<p>Initially 600&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 150&#8211;300&#8239;mg every 3&#8239;days; maintenance 1&#8211;2&#8239;g daily, alternatively maintenance 20&#8211;30&#8239;mg/kg daily; maximum 2.5&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Initiation of valproate treatment",
                        "html": "Initiation of valproate treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 mg/kg, (Usually 400&#8211;800 mg), followed by (by intravenous infusion or by intravenous injection) up to 2.5 g daily in 2&#8211;4 divided doses, alternatively (by continuous intravenous infusion) up to 2.5 g daily; (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 1&#8211;2 g daily, alternatively (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 20&#8211;30 mg/kg daily, intravenous injection to be administered over 3&#8211;5 minutes.",
                        "html": "<p>Initially 10&#8239;mg/kg, (Usually 400&#8211;800&#8239;mg), followed by (by intravenous infusion or by intravenous injection) up to 2.5&#8239;g daily in 2&#8211;4 divided doses, alternatively (by continuous intravenous infusion) up to 2.5&#8239;g daily; (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 1&#8211;2&#8239;g daily, alternatively (by intravenous injection or by intravenous infusion or by continuous intravenous infusion) usual dose 20&#8211;30&#8239;mg/kg daily, intravenous injection to be administered over 3&#8211;5 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Continuation of valproate treatment",
                        "html": "Continuation of valproate treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion or continuous intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion or by continuous intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion or by continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "If switching from oral therapy to intravenous therapy give current oral daily dose, give over 3&#8211;5 minutes by intravenous injection or in 2&#8211;4 divided doses by intravenous infusion.",
                        "html": "<p>If switching from oral therapy to intravenous therapy give current oral daily dose, give over 3&#8211;5 minutes by intravenous injection <i>or</i> in 2&#8211;4 divided doses by intravenous infusion.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Migraine prophylaxis",
                        "html": "Migraine prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using immediate-release medicines"
                    ],
                    "textContent": "By mouth using immediate-release medicines",
                    "html": "By mouth using immediate-release medicines"
                },
                "adult": [
                    {
                        "textContent": "Initially 200 mg twice daily, then increased if necessary to 1.2&#8211;1.5 g daily in divided doses.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased if necessary to 1.2&#8211;1.5&#8239;g daily in divided doses.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Not licensed for migraine prophylaxis.",
                "html": "<p>Not licensed for migraine prophylaxis.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Family history of severe hepatic dysfunction",
                "html": "Family history of severe hepatic dysfunction"
            },
            {
                "type": "contraindications",
                "textContent": "known mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)",
                "html": "known mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)"
            },
            {
                "type": "contraindications",
                "textContent": "personal or family history of severe hepatic dysfunction",
                "html": "personal or family history of severe hepatic dysfunction"
            },
            {
                "type": "contraindications",
                "textContent": "porphyria",
                "html": "porphyria"
            },
            {
                "type": "contraindications",
                "textContent": "suspected mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)",
                "html": "suspected mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Systemic lupus erythematosus",
                "html": "Systemic lupus erythematosus"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Liver toxicity",
                "textContent": "Liver dysfunction (including fatal hepatic failure) has occurred in association with valproate (especially in children under 3 years and in those with metabolic or degenerative disorders, organic brain disease or severe seizure disorders associated with mental retardation) usually in first 6 months and usually involving multiple antiepileptic therapy. Raised liver enzymes during valproate treatment are usually transient but patients should be reassessed clinically and liver function (including prothrombin time) monitored until return to normal&#8212;discontinue if abnormally prolonged prothrombin time (particularly in association with other relevant abnormalities).",
                "html": "<p>Liver dysfunction (including fatal hepatic failure) has occurred in association with valproate (especially in children under 3 years and in those with metabolic or degenerative disorders, organic brain disease or severe seizure disorders associated with mental retardation) usually in first 6 months and usually involving multiple antiepileptic therapy. Raised liver enzymes during valproate treatment are usually transient but patients should be reassessed clinically and liver function (including prothrombin time) monitored until return to normal&#8212;discontinue if abnormally prolonged prothrombin time (particularly in association with other relevant abnormalities).</p>"
            },
            {
                "type": "importantAdvice",
                "textContent": "Consider vitamin D supplementation in patients that are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.",
                "html": "<p>Consider vitamin D supplementation in patients that are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (sodium valproate).",
                "html": "<p>Appendix 1 (sodium valproate).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Aggression",
                        "html": "Aggression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anaemia",
                        "html": "anaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "convulsion",
                        "html": "convulsion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "deafness",
                        "html": "deafness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "extrapyramidal disorders",
                        "html": "extrapyramidal disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastric irritation",
                        "html": "gastric irritation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "haemorrhage",
                        "html": "haemorrhage",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyponatraemia",
                        "html": "hyponatraemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "memory impairment",
                        "html": "memory impairment",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "menstrual disturbance",
                        "html": "menstrual disturbance",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nystagmus",
                        "html": "nystagmus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "somnolence",
                        "html": "somnolence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "stupor",
                        "html": "stupor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "transient hair loss (regrowth may be curly)",
                        "html": "transient hair loss (regrowth may be curly)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight gain",
                        "html": "weight gain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Angioedema",
                        "html": "Angioedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "coma",
                        "html": "coma",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "encephalopathy",
                        "html": "encephalopathy",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "increased alertness",
                        "html": "increased alertness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "lethargy",
                        "html": "lethargy",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pancytopenia",
                        "html": "pancytopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "reduced bone mineral density",
                        "html": "reduced bone mineral density",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "syndrome of inappropriate secretion of antidiuretic hormone",
                        "html": "syndrome of inappropriate secretion of antidiuretic hormone",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vasculitis",
                        "html": "vasculitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Behavioural disturbance",
                        "html": "Behavioural disturbance",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bone marrow failure",
                        "html": "bone marrow failure",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "dementia in adults",
                        "html": "dementia in adults",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare",
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "drug rash with eosinophilia and systemic symptoms (DRESS) syndrome",
                        "html": "drug rash with eosinophilia and systemic symptoms (DRESS) syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "enuresis",
                        "html": "enuresis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Fanconi&#8217;s syndrome",
                        "html": "Fanconi&#8217;s syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hearing loss",
                        "html": "hearing loss",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hyperactivity",
                        "html": "hyperactivity",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hyperammonaemia",
                        "html": "hyperammonaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypothyroidism",
                        "html": "hypothyroidism",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "learning disorders",
                        "html": "learning disorders",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "male infertility",
                        "html": "male infertility",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "myelodysplastic syndrome",
                        "html": "myelodysplastic syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "polycystic ovaries",
                        "html": "polycystic ovaries",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "systemic lupus erythematosus",
                        "html": "systemic lupus erythematosus",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Acne",
                        "html": "Acne",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "gynaecomastia",
                        "html": "gynaecomastia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatic dysfunction",
                        "html": "hepatic dysfunction",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hirsutism",
                        "html": "hirsutism",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "increase in bleeding time",
                        "html": "increase in bleeding time",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hypersensitivity reactions",
                        "html": "Hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "suicidal ideation",
                        "html": "suicidal ideation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hepatic dysfunction",
                "textContent": "Withdraw treatment immediately if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness, or loss of seizure control.",
                "html": "<p>Withdraw treatment immediately if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness, or loss of seizure control.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Valproate is associated with teratogenic risks and should not be used in women of child-bearing potential unless there is no safer alternative&#8212;this should be fully considered and discussed before prescribing for women of child-bearing age.\n\nEffective contraception advised in women of child-bearing potential.",
                "html": "<p>Valproate is associated with teratogenic risks and should not be used in women of child-bearing potential unless there is no safer alternative&#8212;this should be fully considered and discussed before prescribing for women of child-bearing age.</p><p>Effective contraception advised in women of child-bearing potential.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Valproate is associated with the highest risk of major and minor congenital malformations (in particular neural tube defects), and long-term neurodevelopmental effects. Valproate should not be used during pregnancy or in women of child-bearing potential unless there is no safer alternative and only after a careful discussion of the risks.\n\nIf valproate is to be used during pregnancy, the lowest effective dose should be prescribed in divided doses or as modified-release tablets to avoid peaks in plasma-valproate concentrations; doses greater than 1 g daily are associated with an increased risk of teratogenicity.\n\nAvoid use in the treatment of epilepsy and bipolar disorder unless there is no safer alternative and only after a careful discussion of the risks&#8212;effective contraception advised in women of child-bearing potential.\n\nAvoid use for the prophylaxis of migraine [unlicensed]&#8212;exclude pregnancy before treatment and ensure effective contraception is used during treatment.\n\nNeonatal bleeding (related to hypofibrinaemia) reported.\n\nNeonatal hepatotoxicity also reported.",
                "html": "<p>Valproate is associated with the highest risk of major and minor congenital malformations (in particular neural tube defects), and long-term neurodevelopmental effects. Valproate should not be used during pregnancy or in women of child-bearing potential unless there is no safer alternative and only after a careful discussion of the risks. </p><p>If valproate is to be used during pregnancy, the lowest effective dose should be prescribed in divided doses or as modified-release tablets to avoid peaks in plasma-valproate concentrations; doses greater than 1&#8239;g daily are associated with an increased risk of teratogenicity.</p><p>Avoid use in the treatment of epilepsy and bipolar disorder unless there is no safer alternative and only after a careful discussion of the risks&#8212;effective contraception advised in women of child-bearing potential.</p><p>Avoid use for the prophylaxis of migraine [unlicensed]&#8212;exclude pregnancy before treatment and ensure effective contraception is used during treatment.</p><p>Neonatal bleeding (related to hypofibrinaemia) reported.</p><p>Neonatal hepatotoxicity also reported.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Specialist prenatal monitoring should be instigated when valproate has been taken in pregnancy.\n\nThe dose should be monitored carefully during pregnancy and after birth, and adjustments made on a clinical basis.",
                "html": "<p>Specialist prenatal monitoring should be instigated when valproate has been taken in pregnancy.</p><p>The dose should be monitored carefully during pregnancy and after birth, and adjustments made on a clinical basis.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk&#8212;risk of haematological disorders in breast-fed new borns and infants.",
                "html": "<p>Present in milk&#8212;risk of haematological disorders in breast-fed new borns and infants.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if possible&#8212;hepatotoxicity and hepatic failure may occasionally occur (usually in first 6 months).\n\nAvoid in active liver disease.",
                "html": "<p>Avoid if possible&#8212;hepatotoxicity and hepatic failure may occasionally occur (usually in first 6 months).</p><p>Avoid in active liver disease.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose.",
                "html": "<p>Reduce dose.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "textContent": "Plasma-valproate concentrations are not a useful index of efficacy, therefore routine monitoring is unhelpful.",
                "html": "<p>Plasma-valproate concentrations are not a useful index of efficacy, therefore routine monitoring is unhelpful.</p>"
            }
        ],
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor liver function before therapy and during first 6 months especially in patients most at risk.\n\nMeasure full blood count and ensure no undue potential for bleeding before starting and before surgery.",
                "html": "<p>Monitor liver function before therapy and during first 6 months especially in patients most at risk.</p><p>Measure full blood count and ensure no undue potential for bleeding before starting and before surgery.</p>"
            }
        ]
    },
    "effectOnLaboratoryTests": {
        "effectOnLaboratoryTests": [
            {
                "type": "effectOnLaboratoryTests",
                "textContent": "False-positive urine tests for ketones.",
                "html": "<p>False-positive urine tests for ketones.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous injection, may be diluted in Glucose 5% or Sodium Chloride 0.9% and given over 3&#8211;5 minutes.\n\nFor intravenous infusion, dilute injection solution with Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous injection</i>, may be diluted in Glucose 5% <i>or</i> Sodium Chloride 0.9% and given over 3&#8211;5 minutes.</p><p>For <i>intravenous infusion</i>, dilute injection solution with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With rectal use in children",
                    "html": "With <ph outputclass=\"route\">rectal</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "rectal"
                    ]
                },
                "textContent": "For rectal administration, sodium valproate oral solution may be given rectally and retained for 15 minutes (may require dilution with water to prevent rapid expulsion).",
                "html": "<p>For <i>rectal administration</i>, sodium valproate oral solution may be given rectally and retained for 15 minutes (may require dilution with water to prevent rapid expulsion).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Epilim , Episenta ), give continuously or intermittently in Glucose 5% or Sodium Chloride 0.9%. Reconstitute Epilim with solvent provided then dilute with infusion fluid.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Epilim</i>\n<tm tmtype=\"reg\"/>, <i>Episenta</i>\n<tm tmtype=\"reg\"/>), give continuously <i>or</i> intermittently <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%. Reconstitute <i>Epilim</i>\n<tm tmtype=\"reg\"/> with solvent provided then dilute with infusion fluid.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "title": "Switching between formulations",
                "textContent": "Care should be taken when switching between oral formulations in the treatment of epilepsy. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.\n\nPatients being treated for epilepsy may need to be maintained on a specific manufacturer&#8217;s branded or generic oral sodium valproate product.",
                "html": "<p>Care should be taken when switching between oral formulations in the treatment of epilepsy. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p><p>Patients being treated for epilepsy may need to be maintained on a specific manufacturer&#8217;s branded or generic oral sodium valproate product.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Sodium valproate for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures\">www.medicinesforchildren.org.uk/sodium-valproate-for-preventing-seizures</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Blood or hepatic disorders",
                "textContent": "Patients or their carers should be told how to recognise signs and symptoms of blood or liver disorders and advised to seek immediate medical attention if symptoms develop.",
                "html": "<p>Patients or their carers should be told how to recognise signs and symptoms of blood or liver disorders and advised to seek immediate medical attention if symptoms develop.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Pancreatitis",
                "textContent": "Patients or their carers should be told how to recognise signs and symptoms of pancreatitis and advised to seek immediate medical attention if symptoms such as abdominal pain, nausea, or vomiting develop; discontinue if pancreatitis is diagnosed.",
                "html": "<p>Patients or their carers should be told how to recognise signs and symptoms of pancreatitis and advised to seek immediate medical attention if symptoms such as abdominal pain, nausea, or vomiting develop; discontinue if pancreatitis is diagnosed.</p>"
            }
        ],
        "patientAdviceInPregnancy": [
            {
                "type": "patientAdviceInPregnancy",
                "textContent": "Counselling advised on pregnancy.",
                "html": "<p>Counselling advised on pregnancy.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "suppository",
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77460",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77472",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77467",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77482",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77496",
                "label": "Modified-release granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77491",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76148",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77476",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78155",
                "label": "Psychoses and related disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_286",
                "label": "Sodium Valproate",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77460",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77472",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77467",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77482",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77496",
                "label": "Modified-release granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77491",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76148",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77476",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}